Temasek doubles down on India retail as portfolio hits S$518B, backing Haldiram's, Lenskart, Eternal
Singapore's Temasek reaffirmed India as a core long-term market, prioritizing consumer, financial services and healthcare. Its India book spans retail-relevant names like Haldiram's, Lenskart and Eternal, betting on the country's expanding middle class. Group portfolio rose S$49B to S$518B on a 10.5% one-year return.
What happened
Temasek reaffirms India as a core long-term market, prioritizing consumer, financial services and healthcare. Its India portfolio includes retail-relevant names
Key facts
- S$518 billion portfolio
- S$49 billion increase
- 10.5% one-year TSR
- S$51 billion invested
- S$20 billion net investments
Why this matters
A deep-pocketed sovereign investor doubling down on Indian consumer assets raises valuations and competition for quality retail targets, so accelerate partnership or co-investment conversations before entry multiples reset higher.
What to watch
- Lenskart or Eternal IPO filing/pricing news
- Indian middle-class consumption and quick-commerce demand data
- Rupee/INR volatility and RBI policy shifts affecting foreign returns
- Temasek's next portfolio allocation disclosure toward India vs China
- Private-market valuation resets in Indian consumer deals
- Temasek deepens existing stakes and adds new consumer/healthcare positions in India via follow-on rounds
- Portfolio companies (Lenskart, Haldiram's) advance IPO or pre-IPO fundraising timelines
- Rival sovereign wealth and global PE funds increase India consumer allocations to match
- Push for governance and margin improvements at portfolio firms to prep for public exits